Literature DB >> 2473089

Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens.

B Schable1, D L Rhoden, R Hugh, R E Weaver, N Khardori, P B Smith, G P Bodey, R L Anderson.   

Abstract

Twenty-six serotypes of Xanthomonas maltophilia were defined by using 15 antisera described by Hugh and Ryschenkow (R. Hugh and E. Ryschenkow, J. Gen. Microbiol. 26:123-132, 1961) and 11 new antisera. The antisera were prepared by immunizing rabbits with bacterial strains heated at 100 degrees C for 2 h. Twelve antisera required adsorptions with cross-reacting heterologous immunizing strains. We tested 275 clinical and environmental strains of X. maltophilia with 26 antisera by the slide agglutination technique. A total of 259 (94.2%) strains were typeable, with 137 (49.8%) strains agglutinating in three antisera.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473089      PMCID: PMC267473          DOI: 10.1128/jcm.27.5.1011-1014.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Pseudomonas maltophilia, an alcaligenes-like species.

Authors:  R HUGH; E RYSCHENKOW
Journal:  J Gen Microbiol       Date:  1961-09

Review 2.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

3.  Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools.

Authors:  F Grimont; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1986 Sep-Oct

4.  Infrequently encountered Pseudomonas species causing infection in humans.

Authors:  G L Gilardi
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

5.  Nonfermentative gram-negative bacilli of nosocomial interest.

Authors:  P Gardner; W B Griffin; M N Swartz; L J Kunz
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

6.  Pseudomonas maltophilia infections in man.

Authors:  G L Gilardi
Journal:  Am J Clin Pathol       Date:  1969-01       Impact factor: 2.493

7.  Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification.

Authors:  O S Mikkelsen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

8.  Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum.

Authors:  R R Muder; V L Yu; J S Dummer; C Vinson; R M Lumish
Journal:  Arch Intern Med       Date:  1987-09

9.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital.

Authors:  A J Morrison; K K Hoffmann; R P Wenzel
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

10.  Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia.

Authors:  C E Nord; T Wadström; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

View more
  11 in total

1.  Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Prevalence of serotypes of Xanthomonas maltophilia from world-wide sources.

Authors:  B Schable; D L Rhoden; W R Jarvis; J M Miller
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

3.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents.

Authors:  N Khardori; A Reuben; B Rosenbaum; K Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; A Bourdois; P Mariani-Kurkdjian; J P Cezard; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment.

Authors:  F P Laing; K Ramotar; R R Read; N Alfieri; A Kureishi; E A Henderson; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Diversity of nosocomial Xanthomonas maltophilia (Stenotrophomonas maltophilia) as determined by ribotyping.

Authors:  P Gerner-Smidt; B Bruun; M Arpi; J Schmidt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

9.  Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis.

Authors:  J D Yao; J M Conly; M Krajden
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance.

Authors:  Geoffrey A McKay; Donald E Woods; Kelly L MacDonald; Keith Poole
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.